November 2025
Salarius Pharmaceuticals
Canaccord Genuity Advises Salarius Pharmaceuticals on its Merger with Decoy Therapeutics
More Like This
-
C$3.3bPending Completion
dentalcorp
Financial Advisor to dentalcorp Holdings on its Sale to GTCR
-
Kent-Athlone Pharma Group
Exclusive Financial Advisor to Kent-Athlone Pharma Group on the Sale of Athlone Laboratories to Gaelic Laboratories
-
US$140m
Trulieve Cannabis
Sole Agent and Sole Bookrunner (Senior Secured Notes Offering)